Kari Tikkinen presents a urologic subgroup analysis of the POISE-3 trial, examining tranexamic acid versus placebo in approximately 1,100 patients across a range of urologic procedures including robotic prostatectomy, nephrectomy, cystectomy, TURP, and PCNL.
|
